B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration GmbH, Германия|502.78|2|1|0|C|8|5||0|| B03XA01|Erythropoietine /human recombinant|BH050|Binocrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Sandoz GmbH, Австрия|502.78|2|1|0|C|8|5||0|| B02BX04|ROMIPLOSTIM|BH055|NPLATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250 mcg|mcg|1|250|Amgen Europe B.V., Нидерландия|1132.67|3|1|0|C|1|||0|| B03XA01|Erythropoietine /human recombinant|BH056|Retacrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Pfizer Europe MA EEIG, Белгия|502.78|2|1|0|C|8|5||0|| B03XA02|DARBEPOETIN ALFA|BH057|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|300 mcg/0,6 ml|mcg|1|300|Amgen Europe B.V., Нидерландия|781.04|3|1|0|C|8|5||0|| B03XA02|DARBEPOETIN ALFA|BH058|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|150 mcg/0,3 ml|mcg|1|150|Amgen Europe B.V., Нидерландия|390.46|3|1|0|C|8|5||0|| B03XA03|METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA|BH081|MIRCERA|SOL. INJ. PRE-FILLED SYRINGE|150 mcg/0,3 ml|mcg|1|150|Roche Registration GmbH, Германия|439.31|3|1|0|C||5||0|| B02BX05|ELTROMBOPAG|BH085|Revolade|TABL. FILM. COAT.|25 mg|mg|28|700|Novartis Europharm Ltd., Ирландия|1703.2|4|0|0|C|3|||0|| B02BB01|HUMAN FIBRINOGEN|BH087|Haemocomplettan P|POWD.FOR SOL. FOR INJ/INF|1 000 mg|mg|1|1000|CSL Behring GmbH, Германия|713.18||||H|||||| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH088|OCTAPLEX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|375.66||||H|||||| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH089|Prothromplex Total NF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|450.79||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH090|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|1000IU|IU|1|1000|CSL Behring GmbH, Германия|611.64||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH091|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|250IU|IU|1|250|CSL Behring GmbH, Германия|152.91||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH092|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|500IU|IU|1|500|CSL Behring GmbH, Германия|305.82||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH093|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Instituto Grifols S.A., Испания|305.82||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH094|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Instituto Grifols S.A., Испания|152.91||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH095|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Instituto Grifols S.A., Испания|611.64||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH096|Immunate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|305.82||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH097|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|305.82||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH098|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Octapharma (IP) SPRL, Белгия|611.64||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH099|Advate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Takeda Manufacturing Austria AG, Австрия|533.75||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH103|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|533.75||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH104|NovoEight|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A.S., Дания|533.75||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH105|Nuwiq|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma AB, Швеция|533.75||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH106|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|533.75||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH108|Adynovi|POWDER AND SOLVENT FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH110|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|1328.36||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH111|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|332.09||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH112|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH113|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|3985.08||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH114|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|2656.72||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH115|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1500 IU|IU|1|1500|Swedish Orphan Biovitrum AB, Швеция|1992.54||||H|||||| B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH116|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|25 U/ml (500 U)|IU|1|500|Baxalta Innovations GmbH, Австрия|725.51||||H|||||| B02BD04|COAGULATION FACTOR IX|BH118|Aimafix|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|500IU|IU|1|500|Kedrion S.p.A., Италия|391.15||||H|||||| B02BD04|COAGULATION FACTOR IX|BH119|IMMUNINE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|469.38||||H|||||| B02BD04|COAGULATION FACTOR IX|BH120|OCTANINE F 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|391.15||||H|||||| B02BD04|COAGULATION FACTOR IX|BH121|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|2198.54||||H|||||| B02BD04|COAGULATION FACTOR IX|BH122|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|6595.61||||H|||||| B02BD04|COAGULATION FACTOR IX|BH123|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|4397.08||||H|||||| B02BD04|COAGULATION FACTOR IX|BH124|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|1099.27||||H|||||| B02BD04|COAGULATION FACTOR IX|BH125|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|549.64||||H|||||| B02BD04|COAGULATION FACTOR IX|BH126|BeneFIX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|531.43||||H|||||| B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH127|Wilate 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|471.14||||H|||||| B02BD08|EPTACOG ALFA (ACTIVATED)|BH128|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2 mg (100 KIU)|MG|1|2|Novo Nordisk A.S., Дания|2092.51||||H|||||| B02BD08|EPTACOG ALFA (ACTIVATED)|BH129|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|5 mg (250 KIU)|MG|1|5|Novo Nordisk A.S., Дания|5231.27||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH130|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH131|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|Bayer AG, Германия|1328.36||||H|||||| B02BD04|COAGULATION FACTOR IX|BH132|Refixia|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, Дания|1099.27||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH133|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, Дания|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH134|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Novo Nordisk A/S, Дания|1328.36||||H|||||| B02BB01|HUMAN FIBRINOGEN|BH135|Fibryga|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|1000 mg|mg|1|1000|Octapharma (IP) SPRL, Белгия|713.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH136|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|CSL Behring GmbH, Германия|1067.5||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH137|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|CSL Behring GmbH, Германия|266.88||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH138|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|CSL Behring GmbH, Германия|533.75||||H|||||| H02AB02|Dexamethasone|HH003|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 2ml|mg|10|80|Софарма АД, България|15.7|1|0|0|C|2|7||0|| H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|10|40|Софарма АД, България|7.85|1|0|0|C|2|7||0|| H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|25|100|KRKA d.d., Словения|19.63|1|0|0|C|2|7||0|| H01CB02|OCTREOTIDE|HH007|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|20 mg|mg|1|20|Novartis Pharma GmbH, Германия|623.12|2|1|0|C|7|2||0|| H01CB02|OCTREOTIDE|HH008|Sandostatin LAR|POWD. FOR SOL. FOR INFUSION|30 mg|mg|1|30|Novartis Pharma GmbH, Германия|934.79|2|1|0|C|7|2||0|| J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH012|IMMUNOVENIN-INTACT 5% IgG|SOL. FOR INF.|50 mg/ml -5 ml|mg|10|2500|БУЛ БИО-НЦЗПБ ЕООД, България|292.03|1|4|0|C|1|||1|| L01DB03|Epirubicin|LH004|Farmorubicin PFS|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Pfizer Europe MA EEIG, Белгия|43.33|1|4|0|C||1||1|| L01BC01|Cytarabine|LH005|ALEXAN|solution for injection|50 mg/ ml - 20 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|21.44|1|4|0|C||1||1|| L01DB03|Epirubicin|LH015|"EPIRUBICIN ""EBEWE"""|concentrate for solution for injection/ infusion|2 mg/ml- 25 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|43.33|1|4|0|C||1||1|| L01DB03|EPIRUBICIN|LH024|EPISINDAN|SOL. FOR INF.|2 mg/ml - 50 ml|mg|1|100|Тева Фарма ЕАД, България|86.66|1|4|0|C||1||1|| L01CD01|Paclitaxel|LH030|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Ebewe Pharma GmbH. N.fg. KG, Австрия|22.02|1|4|0|C||1||1|| L01CD01|PACLITAXEL|LH046|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Polska , Полша|66.05|1|4|0|C||1||1|| L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Enterprises S.A.R.L., Люксембург|53.88|1|4|0|C||1||1|| L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Enterprises S.A.R.L., Люксембург|107.76|1|4|0|C||1||1|| L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma GmbH. N.fg. KG, Австрия|67.69|1|4|0|C|7|1||1|| L01CA04|VINORELBINE|LH078|Vinorelbin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|68.36|1|4|0|C|8|1||1|| L01BB04|CLADRIBINE|LH108|Litak|SOLUTION FOR INJECTION|2 mg/ml - 5 ml|mg|1|10|Lipomed GmbH, Germany|673.92|3|1|0|C||1||1|| L01XA01|CISPLATIN|LH109|Cisplatin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Polska , Полша|10.72|1|4|0|C||1||1|| L01XA02|Carboplatin|LH113|CARBOPLATIN EBEWE|Concentrate for solution for infusion|10 mg/ml-15 ml|mg|1|150|Ebewe Pharma GmbH. N.fg. KG, Австрия|58.58|1|4|0|C||1||1|| L01BB06|Clofarabine|LH117|EVOLTRA|concentrate for sol. for inf.|1 mg/ml - 20 ml|mg|1|20|Genzyme Europe B.V., Нидерландия|1311.18|1|4|0|C||1||1|| L03AA02|FILGRASTIM|LH123|Nivestim|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Pfizer Europe MA EEIG, Белгия|113.82|3|1|0|C|7|5||0|| L03AA02|Filgrastim|LH128|Zarzio|solution for injection/infusion|30 MU/ 0,5 ml|mcg|5|1500|Sandoz GmbH, Австрия|113.82|3|1|0|C|7|5||0|| L01EH01|LAPATINIB|LH137|Tyverb|FILM-COATED TABLET|250 mg|mg|140|35000|Novartis Europharm Ltd., Ирландия|3412.51|4|0|0|C|3|3||0|| L01EA03|NILOTINIB|LH139|Tasigna|CAPSULE, HARD|200 mg|mg|28|5600|Novartis Europharm Ltd., Ирландия|1519.21|4|0|0|C|3|3||0|| L01EA03|NILOTINIB|LH140|Tasigna|CAPSULE, HARD|150 mg|mg|28|4200|Novartis Europharm Ltd., Ирландия|1139.81|4|0|0|C|3|3||0|| L01XC02|Rituximab|LH154|MabThera|concentrate for sol. for inf.|100|mg|2|200|Roche Registration GmbH, Германия|342.03|1|4|0|C||3||1|| L01XC02|Rituximab|LH155|MabThera|concentrate for sol. for inf.|500|mg|1|500|Roche Registration GmbH, Германия|855.08|1|4|0|C||3||1|| L01EG01|TEMSIROLIMUS|LH158|Torisel|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INJ.|30 mg|mg|1|30|Pfizer Europe MA EEIG, Белгия|1436.9|1|4|0|C||3||1|| L01FE01|CETUXIMAB|LH160|ERBITUX|SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Merck Europe B.V., Нидерландия|345.74|1|4|0|C|7|3||1|| L01XC07|Bevacizumab|LH161|Avastin|concentrate for solution for infusion|25 mg/ml-4 ml|mg|1|100|Roche Registration GmbH, Германия|310.2|1|4|0|C|8|3||1|| L01XE10|EVEROLIMUS|LH162|Afinitor|TABL|5 mg|mg|30|150|Novartis Europharm Ltd., Ирландия|1310.62|4|0|0|C|3|3||0|| L01XC07|Bevacizumab|LH163|Avastin|concentrate for solution for infusion|25 mg/ml-16 ml|mg|1|400|Roche Registration GmbH, Германия|1219.42|1|4|0|C|8|3||1|| L01XE10|EVEROLIMUS|LH164|Afinitor|TABL|10 mg|mg|30|300|Novartis Europharm Ltd., Ирландия|2621.24|4|0|0|C|3|3||0|| L01FE02|PANITUMUMAB|LH165|Vectibix|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Amgen Eurоpe B.V., Нидерландия|673.72|1|4|0|C|8|3||1|| L01EX03|PAZOPANIB|LH166|Votrient|FILM-COATED TABLET|200 mg|mg|30|6000|Novartis Europharm Ltd., Ирландия|704.03|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH170|Votrient|FILM-COATED TABLET|400 mg|mg|60|24000|Novartis Europharm Ltd., Ирландия|2816.1|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH172|Sutent|CAPSULE, HARD|12,5 mg|mg|30|375|Pfizer Europe MA EEIG, Белгия|1051.8|4|0|0|C|3|3||0|| L01CE01|TOPOTECAN|LH175|Hycamtin|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|4 mg|mg|1|4|Novartis Europharm Ltd., Ирландия|122.04|1|4|0|C||1||1|| L01EX01|SUNITINIB|LH176|Sutent|CAPSULE, HARD|25 mg|mg|30|750|Pfizer Europe MA EEIG, Белгия|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH177|Sutent|CAPSULE, HARD|50 mg|mg|30|1500|Pfizer Europe MA EEIG, Белгия|4207.21|4|0|0|C|3|3||0|| L01EX02|SORAFENIB|LH179|Nexavar|TABL. FILM. COAT.|200 mg|mg|112|22400|Bayer AG, Германия|2222.38|4|0|0|C|3|3||0|| L01EA02|DASATINIB|LH181|Sprycel|TABL. FILM. COAT.|50 mg|mg|60|3000|Bristol-Myers Squibb Pharma EEIG, Ирландия|2644.67|4|0|0|C|3|3||0|| L01CE01|TOPOTECAN|LH184|Hycamtin|CAPSULE, HARD|1 mg|mg|10|10|Novartis Europharm Ltd., Ирландия|538.15|4|0|0|C|3|1||0|| L01BA01|Methotrexate|LH187|METHOTREXATE EBEWE|concentrate for solution for infusion|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|32.99|1|4|0|C||1||1|| L01XX23|MITOTANE|LH202|Lysodren|TABL|500 mg|mg|100|50000|HRA Pharma Rare Disease|1164.86|4|0|0|C|3|1||0|| L03AX16|Plerixafor|LH218|Mozobil|solution for injection|20 mg/ml - 1,2 ml|mg|1|24|Genzyme Europe B.V., Нидерландия|10653.59|3|1|0|C||5||0|| L01BB05|FLUDARABINE|LH219|Fludarabine Actavis|POWD.FOR SOL. FOR INJ/INF|50 mg|mg|1|50|Тева Фарма ЕАД, България|92.04|1|4|0|C||1||1|| L01XA03|Oxaliplatin|LH227|Oxaliplatin-Tchaikapharma|powder for solution for infusion|100|mg|1|100|Чайкафарма - Висококачествените лекарства АД, България|30.44|1|3|0|C||1||1|| L01CD02|DOCETAXEL|LH230|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|80 mg/ 4 ml|mg|1|80|Accord Healthcare S.L.U., Испания|33.24|1|2|0|C||1||1|| L01CE01|TOPOTECAN|LH233|Topotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 4 ml|mg|1|4|Accord Healthcare Polska , Полша|122.04|1|4|0|C||1||1|| L03AA13|PEGFILGRASTIM|LH234|Neulasta|SOLUTION FOR INJECTION|6 mg|mg|1|6|Amgen Europe B.V., Нидерландия|619.87|2|1|0|C|7|5||0|| L01XA03|OXALIPLATIN|LH237|OXALIPLATIN ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Accord Healthcare Polska , Полша|30.44|1|3|0|C||1||1|| L04AD01|Ciclosporin|LH243|Sandimmun Neoral|caps. soft|25|mg|50|1250|Novartis Pharma GmbH, Германия|30.38|4|0|0|C|3|||0|| L04AD01|Ciclosporin|LH244|Sandimmun Neoral|caps. soft|50|mg|50|2500|Novartis Pharma GmbH, Германия|60.76|4|0|0|C|3|||0|| L04AD01|Ciclosporin|LH253|Sandimmun Neoral|oral solution|100 mg/ml - 50 ml|mg|1|5000|Novartis Pharma GmbH, Германия|136.69|4|0|0|C|3|||0|| L01BC05|GEMCITABINE|LH260|GEMCITABINE ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|35.92|1|4|0|C|8|1||1|| L01CD04|Cabazitaxel|LH274|Jevtana|concentrate and solvent for solution for infusion|60|mg|1|60|Sanofi Aventis, Франция|5248.72|1|4|0|C||1||1|| L01DB01|DOXORUBICIN|LH275|Doxorubicin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|Accord Healthcare Polska , Полша|16.67|1|3|0|C|7|1||1|| L01DB01|DOXORUBICIN|LH281|Myocet liposomal|POWDER, DISPERSION AND CONCENTRATE FOR DISPERSION FOR INFUSION|50 mg|mg|2|100|Teva B.V, Нидерландия|1339.44|1|2|0|C|7|1||1|| L01BC01|CYTARABINE|LH288|Cytarabine Accord|SOL. FOR INJ/INF|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|29.28|1|4|0|C||1||1|| L01BC06|CAPECITABINE|LH291|Capecitabine Accord|TABL. FILM. COAT.|500 mg|mg|120|60000|Accord Healthcare S.L.U., Испания|92.58|4|0|0|C|3|1||0|| L01BC53|tegafur/gimeracil/oteracil|LH302|Teysuno|hard caps.|20 mg/5,8 mg/15,8 mg|mg|84|1680|Nordic Group BV, Холандия|623.63|4|0|0|C|3|1||0|| L01XC11|IPILIMUMAB|LH303|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|Bristol-Myers Squibb Pharma EEIG, Ирландия|26333.11|1|4|0|C||4||1|| L01XC11|IPILIMUMAB|LH304|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, Ирландия|6583.28|1|4|0|C||4||1|| L01EC01|VEMURAFENIB|LH305|ZELBORAF|TABL. FILM. COAT.|240 mg|mg|56|13440|Roche Registration GmbH, Германия|2681.15|4|0|0|C|3|3||0|| L01XX41|ERIBULIN|LH306|Halaven|SOL.FOR INJ|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Eisai GmbH, Германия|721.73|1|4|0|C||1||1|| L01BC02|FLUOROURACIL|LH309|Fluorouracil Accord|SOL. FOR INJ/INF|50 mg/ml - 20 ml|mg|1|1000|Accord Healthcare Polska , Полша|5.02|1|4|0|C|8|1||1|| L01XC03|Trastuzumab|LH310|Herceptin|solution for injection|600 mg/5 ml|mg|1|600|Roche Registration GmbH, Германия|2247.05|3|1|0|C|8|3||0|| L01CD01|PACLITAXEL|LH317|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Accord Healthcare Polska , Полша|22.02|1|4|0|C||1||1|| L01XC02|Rituximab|LH320|MabThera|sol. for inj.|1400mg/11.7 ml|mg|1|1400|Roche Registration GmbH, Германия|3194.37|3|1|0|C||3||0|| L01XX35|ANAGRELIDE|LH321|THROMBOREDUCTIN|CAPSULE, HARD|0.5 mg|mg|100|50|AOP Orphan Pharmaceuticals GmbH, Австрия|228.71|4|0|0|C|3|||0|| L01EA01|IMATINIB|LH324|Meaxin|TABL. FILM. COAT.|100 mg|mg|120|12000|KRKA d.d., Словения|170.87|4|0|0|C|3|3||0|| L01DB03|EPIRUBICIN|LH332|Episindan|SOL.FOR INJ|2 mg/ml - 25 ml|mg|1|50|Тева Фарма ЕАД, България|43.33|1|4|0|C||1||1|| L01FX05|BRENTUXIMAB VEDOTIN|LH334|ADCETRIS|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg|mg|1|50|Takeda Pharma A/S, Дания|6268.44|1|3|0|C||3||1|| L01XC13|Pertuzumab|LH335|Perjeta|concentrate for solution for infusion|420|mg|1|420|Roche Registration GmbH, Германия|4473.1|1|2|0|C|8|3||0|| L01EB03|AFATINIB|LH336|GIOTRIF|FILM-COATED TABLET|30 mg|mg|28|840|Boehringer Ingelheim International GmbH, Германия|2713.83|4|0|0|C|3|3||0|| L01EB03|AFATINIB|LH337|GIOTRIF|FILM-COATED TABLET|40 mg|mg|28|1120|Boehringer Ingelheim International GmbH, Германия|3618.44|4|0|0|C|3|3||0|| L01ED01|CRIZOTINIB|LH338|XALKORI|CAPSULE, HARD|250 mg|mg|60|15000|Pfizer Europe MA EEIG, Белгия|8960.11|4|0|0|C|3|3||0|| L01EK01|AXITINIB|LH339|INLITA|TABL. FILM. COAT.|5 mg|mg|56|280|Pfizer Europe MA EEIG, Белгия|6699.6|4|0|0|C|3|3||0|| L01EJ01|RUXOLITINIB|LH340|JAKAVI|TABL|5 mg|mg|56|280|Novartis Europharm Ltd., Ирландия|3275.81|4|0|0|C|3|3||0|| L01XX44|Aflibercept|LH341|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 8 ml|mg|1|200|Sanofi Aventis Groupe, Франция|1233.85|1|3|0|C|8|3||1|| L01XX44|Aflibercept|LH342|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 4 ml|mg|1|100|Sanofi Aventis Groupe, Франция|616.93|1|3|0|C|8|3||1|| L03AA14|LIPEGFILGRASTIM|LH344|LONQUEX|SOL. INJ. PRE-FILLED SYRINGE|6mg/0.6ml|mg|1|6|Teva B.V, Нидерландия|932.47|3|1|0|C|7|5||0|| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH348|Bendamustine Actavis|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Teva B.V, Нидерландия|179.77|1|4|0|C|6|1||1|| L01XX32|BORTEZOMIB|LH349|Vortemyel|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Zentiva k.s., Чешка република|150|1|4|0|C||3||1|| L01XX32|BORTEZOMIB|LH354|Bortezomib Actavis|POWD.INJ|3.5 mg|mg|1|3.5|Teva B.V, Нидерландия|150|1|4|0|C||3||1|| L01XC14|Trastuzumab emtansine|LH358|Kadcyla|powder for concentrate for sol. for inf.|100 mg/5 ml|mg|1|100|Roche Registration GmbH, Германия|3235.35|1|2|0|C||3||1|| L01XC14|Trastuzumab emtansine|LH359|Kadcyla|powder for concentrate for solution for infusion|160 mg/8 ml|mg|1|160|Roche Registration GmbH, Германия|5176.56|1|2|0|C||3||1|| L01XE12|Vandetanib|LH360|Caprelsa|film-coated tabl.|100|mg|30|3000|Genzyme Europe B.V., Нидерландия|2796.93|4|0|0|C|3|3||0|| L01XE12|Vandetanib|LH361|Caprelsa|film-coated tabl.|300|mg|30|9000|Genzyme Europe B.V., Нидерландия|8390.77|4|0|0|C|3|3||0|| L01EA04|BOSUTINIB|LH362|Bosulif|FILM-COATED TABLET|100 mg|mg|28|2800|Pfizer Europe MA EEIG, Белгия|1178.71|4|0|0|C|3|3||0|| L01EA04|BOSUTINIB|LH363|Bosulif|FILM-COATED TABLET|500 mg|mg|28|14000|Pfizer Europe MA EEIG, Белгия|5893.57|4|0|0|C|3|3||0|| L01EC02|DABRAFENIB|LH364|Tafinlar|CAPSULE, HARD|75 mg|mg|120|9000|Novartis Europharm Ltd., Ирландия|10536.64|4|0|0|C|3|3||0|| L01XJ01|VISMODEGIB|LH365|Erivedge|CAPSULE, HARD|150 mg|mg|28|4200|Roche Registration GmbH, Германия|9145.97|4|0|0|C|3|3||0|| L01AA02|CHLORAMBUCIL|LH366|Leukeran|TABL. FILM. COAT.|2 mg|mg|25|50|Aspen Pharma Trading Ltd., Ирландия|24.83|4|0|0|C|3|1||0|| L01BA04|PEMETREXED|LH367|Pemetrexed Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Sandoz GmbH, Австрия|939.06|1|2|0|C|7|1||1|| L01BB02|MERCAPTOPURINE|LH368|Puri-Nethol|TABL|50 mg|mg|25|1250|Aspen Pharma Trading Ltd., Ирландия|24.23|4|0|0|C|3|1||0|| L01XC21|Ramucirumab|LH370|Cyramza|concentrate for sol. for inf.|10 mg/ml – 10 ml|mg|2|200|Eli Lilly Nederland B.V., Нидерландия|1607.95|1|3|0|C||3||1|| L01BA04|PEMETREXED|LH372|Pemetrexed Alvogen|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg|mg|1|500|Zentiva k.s., Чешка република|939.06|1|2|0|C|7|1||1|| L01BA04|PEMETREXED|LH375|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Actavis Group PTC ehf., Исландия|939.06|1|2|0|C|7|1||1|| L01BA04|PEMETREXED|LH376|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|1878.12|1|2|0|C|7|1||1|| L01AX03|TEMOZOLOMIDE|LH379|Temozolomide Accord|CAPSULE, HARD|100 mg|mg|5|500|Accord Healthcare S.L.U., Испания|85.93|4|0|0|C|3|1||0|| L01BC02|FLUOROURACIL|LH382|5-Fluorouracil Ebewe|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|50 mg/ml - 20 ml|mg|10|10000|Ebewe Pharma GmbH. N.fg. KG, Австрия|50.2|1|4|0|C|8|1||1|| L03AX03|Mycobacterium bovis BCG|LH386|CALGEVAX|Powder for suspension|11.25|mg|4|45|БУЛ БИО-НЦЗПБ ЕООД, България|165.34|1|4|0|C|6|4||0|| L01BA04|PEMETREXED|LH387|Pemetrexed Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Accord Healthcare S.L.U., Испания|939.06|1|2|0|C|7|1||1|| L01EL01|IBRUTINIB|LH390|Imbruvica|CAPSULE, HARD|140|mg|90|12600|Janssen-Cilag International N.V., Белгия|11223.84|4|0|0|C|3|3||0|| L01EK01|AXITINIB|LH393|Inlyta|TABL. FILM. COAT.|1 mg|mg|56|56|Pfizer Europe MA EEIG, Белгия|1339.92|4|0|0|C|3|3||0|| L01FF02|РEMBROLIZUMAB|LH399|Keytruda|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Merck Sharp & Dohme B.V., Нидерландия|5834.29|1|2|0|C||4||0|| L01EA01|IMATINIB|LH402|Imatinib Teva Pharma|TABL. FILM. COAT.|100 mg|mg|120|12000|Teva B.V, Нидерландия|170.87|4|0|0|C|3|3||0|| L01EB02|ERLOTINIB|LH404|Erlotinib Sandoz|TABL. FILM. COAT.|100 mg|mg|30|3000|Sandoz d.d., Словения|764.95|4|0|0|C|3|3||0|| L01EB02|ERLOTINIB|LH405|Erlotinib Actavis|TABL. FILM. COAT.|100 mg|mg|30|3000|Actavis Group PTC ehf., Исландия|764.95|4|0|0|C|3|3||0|| L01EB02|ERLOTINIB|LH406|Erlotinib Actavis|TABL. FILM. COAT.|150 mg|mg|30|4500|Actavis Group PTC ehf., Исландия|1147.43|4|0|0|C|3|3||0|| L01DB11|PIXANTRONE|LH408|Pixuvri|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|29mg|mg|1|29|Les Laboratoires Servier, Франция|916.25|1|4|0|C||1||1|| L01XC15|Obinutuzumab|LH409|Gazyvaro|Concentrate for solution for infusion|1000 mg - 40 ml|mg|1|1000|Roche Registration GmbH, Германия|5997.56|1|4|0|C||3||1|| L01XC17|NIVOLUMAB|LH410|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Bristol-Myers Squibb Pharma EEIG, Ирландия|2316.58|1|2|0|C||4||1|| L01XC17|NIVOLUMAB|LH411|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml-4ml|mg|1|40|Bristol-Myers Squibb Pharma EEIG, Ирландия|926.63|1|2|0|C||4||1|| L01FX07|BLINATUMOMAB|LH412|Blincyto|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|38.5mg|mcg|1|38.5|Amgen Eurоpe B.V., Нидерландия|4787.53|1|2|0|C||3||1|| L01EX05|REGORAFENIB|LH414|Stivarga|FILM-COATED TABLET|40 mg|mg|84|3360|Bayer AG, Германия|4751.74|4|0|0|C|3|3||0|| L01EA05|PONATINIB|LH415|Iclusig|FILM-COATED TABLET|15 mg|mg|60|900|Incyte Biosciences Distribution B.V., Нидерландия|12293.9|4|0|0|C|3|3||0|| L01EF01|PALBOCICLIB|LH416|Ibrance|CAPSULE, HARD|75 mg|mg|21|1575|Pfizer Europe MA EEIG, Белгия|2756.58|4|0|0|C|3|3||0|| L01EF01|PALBOCICLIB|LH417|Ibrance|CAPSULE, HARD|100 mg|mg|21|2100|Pfizer Europe MA EEIG, Белгия|3675.44|4|0|0|C|3|3||0|| L01EF01|PALBOCICLIB|LH418|Ibrance|CAPSULE, HARD|125 mg|mg|21|2625|Pfizer Europe MA EEIG, Белгия|4594.3|4|0|0|C|3|3||0|| L01EB04|OSIMERTINIB|LH419|Tagrisso|FILM-COATED TABLET|40 mg|mg|28|1120|Astra Zeneca AB, Швеция|5929.36|4|0|0|C|3|3||0|| L01EB04|OSIMERTINIB|LH420|Tagrisso|FILM-COATED TABLET|80 mg|mg|28|2240|Astra Zeneca AB, Швеция|11858.72|4|0|0|C|3|3||0|| L01XG02|CARFILZOMIB|LH421|Kyprolis|POWDER FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Amgen Eurоpe B.V., Нидерландия|2211.84|1|4|0|C||3||1|| L01XX52|venetoclax|LH426|Venclyxto|Film coated tablet|100|mg|112|11200|AbbVie Deutchland GmbH & Co. KG, Германия|10559.7|4|0|0|C|3|3||0|| L01EB02|ERLOTINIB|LH427|Erlotinib Sandoz|TABL. FILM. COAT.|150 mg|mg|30|4500|Sandoz d.d., Словения|1147.43|4|0|0|C|3|3||0|| L01AA01|Cyclophosphamide|LH430|Endoxan|Powder for solution for injection|500|mg|1|500|Екофарм Груп АД, България|26.36|1|4|0|C|7|1||1|| L01XX32|Bortezomib|LH432|Bortezocon|Powder for solution for injection|3.5|mg|1|3.5|Фармаконс АД, България|150|1|4|0|C||3||1|| L01AA06|Ifosfamide|LH433|Holoxan|Powder for solution for infusion|2000|mg|1|2000|Екофарм Груп АД, България|188.84|1|4|0|C||1||1|| L01XA03|Oxaliplatin|LH435|Oxaliplatin Bulgermed VE|Concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Булгермед ВЕ ООД, България|30.44|1|3|0|C||1||1|| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH438|Bendamustine Mylan|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|2 mg/ml - 50 ml|mg|5|500|Mylan Pharmaceuticals Limited, Ирландия|898.84|1|4|0|C|6|1||1|| L01BB06|CLOFARABINE|LH439|Clofarabin Zentiva|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 20ml|mg|1|20|Zentiva k.s., Чешка република|1311.18|1|4|0|C||1||1|| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH440|Bendamustine Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|5|500|Accord Healthcare Polska , Полша|898.84|1|4|0|C|6|1||1|| L03AA02|FILGRASTIM|LH442|Accofil|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|30 MU (300 mcg/0.5 ml)|mcg|5|1500|Accord Healthcare S.L.U., Испания|113.82|3|1|0|C|7|5||0|| L01BA01|METHOTREXATE|LH443|Methotrexate Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|32.99|1|4|0|C||1||1|| L01XC03|TRASTUZUMAB|LH444|Kanjinti|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Amgen Eurоpe B.V., Нидерландия|434.46|1|4|0|C||3||1|| L01XC03|TRASTUZUMAB|LH445|Kanjinti|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|420 MG|mg|1|420|Amgen Eurоpe B.V., Нидерландия|1216.49|1|4|0|C||3||1|| L01CE02|IRINOTECAN|LH446|Irinotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , Полша|29.56|1|3|0|C||1||1|| L02BX03|ABIRATERONE ACETATE|LH447|Zytiga|TABLETS FILM COATED|500 mg|mg|60|30000|Janssen-Cilag International N.V., Белгия|1903.12|4|0|0|C|3|2||0|| L01CB01|ETOPOSIDE|LH450|Etoposide Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , Полша|12.08|1|4|0|C||1||1|| L01XC02|Rituximab|LH454|Rixathon|Concentrate for solution for infusion|100 mg/10 ml|mg|2|200|Sandoz GmbH, Австрия|342.03|1|4|0|C||3||1|| L01XC02|Rituximab|LH455|Rixathon|Concentrate for solution for infusion|500 mg/50 ml|mg|1|500|Sandoz GmbH, Австрия|855.08|1|4|0|C||3||1|| L01CD01|PACLITAXEL|LH456|Paclitaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Булгермед ВЕ ООД, България|66.05|1|4|0|C||1||1|| L01XX32|Bortezomib|LH457|Bortezomib Sandoz|Powder for solution for injection|3.5|mg|1|3.5|Sandoz d.d., Словения|150|1|4|0|C||3||1|| L01XC02|Rituximab|LH458|MabThera|Solution for injection|1600 mg/13.4 ml|mg|1|1600|Roche Registration GmbH, Германия|3650.71|3|1|0|C||3||0|| L01BC59|TRIFLURIDINE/TIPIRACIL|LH459|Lonsurf|TABL. FILM. COAT.|15mg/6.14mg|MG|20|300|Les Laboratoires Servier, Франция|1111.03|4|0|0|C|3|1||0|| L01CD02|DOCETAXEL|LH460|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Accord Healthcare S.L.U., Испания|66.47|1|2|0|C||1||1|| L01BC59|TRIFLURIDINE/TIPIRACIL|LH461|Lonsurf|TABL. FILM. COAT.|20mg/8.19mg|MG|20|400|Les Laboratoires Servier, Франция|1477.04|4|0|0|C|3|1||0|| L01XA03|OXALIPLATIN|LH463|Oxaliplatin Bulgermed VE|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|Булгермед ВЕ ООД, България|60.88|1|3|0|C||1||1|| L01FC01|DARATUMUMAB|LH464|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 MG/ ML - 20ML|mg|1|400|Janssen-Cilag International N.V., Белгия|3376.16|1|4|0|C||4||1|| L01ED03|ALECTINIB|LH465|Alecensa|CAPSULE, HARD|150 mg|mg|224|33600|Roche Registration GmbH, Германия|9795.07|4|0|0|C|3|3||0|| L01XG03|IXAZOMIB|LH466|Ninlaro|CAPSULE, HARD|2.3 mg|mg|3|6.9|Takeda Pharma A/S, Дания|4541.3|4|0|0|C|3|3||0|| L01XG03|IXAZOMIB|LH467|Ninlaro|CAPSULE, HARD|3 mg|mg|3|9|Takeda Pharma A/S, Дания|5923.43|4|0|0|C|3|3||0|| L01XG03|IXAZOMIB|LH468|Ninlaro|CAPSULE, HARD|4 mg|mg|3|12|Takeda Pharma A/S, Дания|7897.91|4|0|0|C|3|3||0|| L01XC26|INOTUZUMAB OZOGAMICIN|LH469|BESPONSA|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|1 mg|mg|1|1|Pfizer Europe MA EEIG, Белгия|21175.09|1|4|0|C||4||1|| L01FF05|ATEZOLIZUMAB|LH470|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|1200 mg - 20 ml|mg|1|1200|Roche Registration GmbH, Германия|7597.3|1|2|0|C||4||0|| L01XE10|EVEROLIMUS|LH471|Everolimus Mylan|TABL|5 mg|mg|30|150|Mylan Iraland Limited, Ирландия|1310.62|4|0|0|C|3|3||0|| L01XE10|EVEROLIMUS|LH472|Everolimus Mylan|TABL|10 mg|mg|30|300|Mylan Iraland Limited, Ирландия|2621.24|4|0|0|C|3|3||0|| L01XE10|EVEROLIMUS|LH473|Everolimus Teva|TABL|10 mg|mg|30|300|Teva B.V, Нидерландия|2621.24|4|0|0|C|3|3||0|| L01XC03|TRASTUZUMAB|LH474|Trazimera|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Pfizer Enterprises S.A.R.L., Люксембург|434.46|1|4|0|C||3||1|| L03AA13|PEGFILGRASTIM|LH476|Pelgraz|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Accord Healthcare S.L.U., Испания|619.87|2|1|0|C|7|5||0|| L03AA13|PEGFILGRASTIM|LH477|Ziextenzo|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Sandoz GmbH, Австрия|619.87|2|1|0|C|7|5||0|| L01XC03|TRASTUZUMAB|LH478|Ogivri|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Viatris Limited, Ирландия|434.46|1|4|0|C||3||1|| L01XG02|CARFILZOMIB|LH479|Kyprolis|POWDER FOR SOLUTION FOR INFISION|10 mg|mg|1|10|Amgen Eurоpe B.V., Нидерландия|368.64|1|4|0|C||3||1|| L01XG02|CARFILZOMIB|LH480|Kyprolis|POWDER FOR SOLUTION FOR INFISION|30 mg|mg|1|30|Amgen Eurоpe B.V., Нидерландия|1105.92|1|4|0|C||3||1|| L03AA13|PEGFILGRASTIM|LH481|Pelmeg|SOL.FOR INJ|10mg/ml-0.6 ml|mg|1|6|Mundipharma Corporation (Ireland) Limited, Ирландия|619.87|2|1|0|C|7|5||0|| L01EB01|GEFITINIB|LH482|Gefitinib Teva|TABL. FILM. COAT.|250 mg|mg|30|7500|Teva B.V, Нидерландия|774.77|4|0|0|C|3|3||0|| L01CE02|IRINOTECAN|LH483|Irinotecan Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|MG|1|100|Булгермед ВЕ ООД, България|29.56|1|3|0|C||1||1|| L01XK01|OLAPARIB|LH484|Lynparza|TABL. FILM. COAT.|150 mg|MG|56|8400|Astra Zeneca AB, Швеция|5216.89|4|0|0|C|3|3||0|| L01XK01|OLAPARIB|LH485|Lynparza|TABL. FILM. COAT.|100 mg|MG|56|5600|Astra Zeneca AB, Швеция|3476.68|4|0|0|C|3|3||0|| L01FC01|DARATUMUMAB|LH490|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Janssen-Cilag International N.V., Белгия|844.04|1|4|0|C||4||1|| L01XC05|GEMTUZUMAB OZOGAMICIN|LH491|Mylotarg|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|5 mg|mg|1|5|Pfizer Europe MA EEIG, Белгия|15854.22|1|4|0|C|7|4||1|| L01XC28|DURVALUMAB|LH492|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 10 ml|mg|1|500|Astra Zeneca AB, Швеция|4632.95|1|3|0|C||3||1|| L01XC28|DURVALUMAB|LH493|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 2.4 ml|mg|1|120|Astra Zeneca AB, Швеция|1111.91|1|3|0|C||3||1|| L01EE01|TRAMETINIB|LH494|Mekinist|FILM-COATED TABLET|2 mg|mg|30|60|Novartis Europharm Ltd., Ирландия|8264.81|4|0|0|C|3|3||0|| L01XE39|MIDOSTAURIN|LH495|Rydapt|CAPS. SOFT|25 mg|mg|112|2800|Novartis Europharm Ltd., Ирландия|27002.46|4|0|0|C|3|3||0|| L01XE42|RIBOCICLIB|LH497|Kisqali|TABL. FILM. COAT.|200 mg|mg|21|4200|Novartis Europharm Ltd., Ирландия|1800.9|4|0|0|C|3|3||0|| L01EE02|COBIMETINIB|LH498|Cotellic|TABL. FILM. COAT.|20 mg|mg|63|1260|Roche Registration GmbH, Германия|10680.36|4|0|0|C|3|3||0|| L01BA04|PEMETREXED|LH500|Pemetrexed Novamed|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Новамед Трейдинг ЕООД, България|939.06|1|2|0|C|7|1||1|| L01CD02|DOCETAXEL|LH501|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|mg|1|160|Новамед Трейдинг ЕООД, България|66.47|1|2|0|C||1||1|| L01CD02|DOCETAXEL|LH502|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80|Новамед Трейдинг ЕООД, България|33.24|1|2|0|C||1||1|| L01CE02|IRINOTECAN|LH503|IRINOTECAN NOVAMED|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Новамед Трейдинг ЕООД, България|29.56|1|3|0|C||1||1|| L01FF04|AVELUMAB|LH504|Bavencio|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 10 ml|mg|1|200|Merck Europe B.V., Нидерландия|1540.69|1|3|0|C||4||1|| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH505|Bendamustine Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Sandoz d.d., Словения|179.77|1|4|0|C|6|1||1|| L01EF03|ABEMACICLIB|LH506|Verzenios|TABL. FILM. COAT.|150 mg|mg|42|6300|Eli Lilly Nederland B.V., Нидерландия|3863.94|4|0|0|C|3|3||0|| L01EF03|ABEMACICLIB|LH507|Verzenios|TABL. FILM. COAT.|100 mg|mg|42|4200|Eli Lilly Nederland B.V., Нидерландия|2575.96|4|0|0|C|3|3||0|| L01EF03|ABEMACICLIB|LH508|Verzenios|TABL. FILM. COAT.|50 mg|mg|42|2100|Eli Lilly Nederland B.V., Нидерландия|1287.98|4|0|0|C|3|3||0|| L01XF03|BEXAROTENE|LH509|Targretin|CAPSULE, SOFT|75 mg|mg|100|7500|Eisai GmbH, Германия|1469.02|4|0|0|C|3|3||0|| L01EX09|NINTEDANIB|LH510|Vargatef|CAPSULE, SOFT|150 mg|mg|60|9000|Boehringer Ingelheim International GmbH, Германия|3570.1|4|0|0|C|3|1||0|| L01EX09|NINTEDANIB|LH511|Vargatef|CAPSULE, SOFT|100 mg|mg|120|12000|Boehringer Ingelheim International GmbH, Германия|4761.14|4|0|0|C|3|1||0|| L01XX24|PEGASPARGASE|LH512|Oncaspar|POWD.FOR SOL. FOR INJ/INF|750 U/ml - 3750 U|IU|1|3750|Les Laboratoires Servier, Франция|3568.63|1|3|0|C||1||1|| L04AX04|LENALIDOMIDE|LH513|Lenalidomid Alvogen|CAPSULE, HARD|5 mg|mg|21|105|Алвоген Фарма Трейдинг Юръп ЕООД, България|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH514|Lenalidomid Alvogen|CAPSULE, HARD|10 mg|mg|21|210|Алвоген Фарма Трейдинг Юръп ЕООД, България|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH515|Lenalidomid Alvogen|CAPSULE, HARD|25 mg|mg|21|525|Алвоген Фарма Трейдинг Юръп ЕООД, България|3582.74|4|0|0|C|3|1||0|| L01XE43|BRIGATINIB|LH517|Alunbrig|TABL. FILM. COAT.|30 mg|mg|28|840|Takeda Pharma A/S, Дания|1382.43|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH518|Alunbrig|TABL. FILM. COAT.|90 mg|mg|28|2520|Takeda Pharma A/S, Дания|4147.29|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH519|Alunbrig|TABL. FILM. COAT.|180 mg|mg|28|5040|Takeda Pharma A/S, Дания|8294.59|4|0|0|C|3|3||0|| L04AX06|POMALIDOMIDE|LH520|Imnovid|CAPSULE, HARD|4 mg|mg|21|84|Bristol-Myers Squibb Pharma EEIG, Ирландия|16918.24|4|0|0|C|3|1||0|| L02BB04|ENZALUTAMIDE|LH522|Xtandi|TABL. FILM. COAT.|40 mg|mg|112|4480|Astellas Pharma Europe B.V., Нидерландия|5771.2|4|0|0|C|3|2||0|| L01FF05|ATEZOLIZUMAB|LH523|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|840mg - 14ml|mg|1|840|Roche Registration GmbH, Германия|5318.11|1|2|0|C||4||0|| L01CD01|PACLITAXEL|LH524|Pazenir|POWDER FOR DISPERSION FOR INFUSION|5mg/ml|mg|1|100|Ratiopharm GmbH, Германия|270.36|1|3|0|C||1||1|| L01XC03|TRASTUZUMAB|LH525|Ontruzant|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|mg|1|150|Samsung Bioepis NL B.V., Нидерландия|434.46|1|4|0|C||3||1|| L01EB01|GEFITINIB|LH526|Gefitinib Pharmascience|FILM-COATED TABLET|250 mg|mg|30|7500|Pharmascience International Ltd., Кипър|774.77|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH528|Alunbrig|TABL. FILM. COAT.|90 mg + 180 mg|mg|28|4410|Takeda Pharma A/S, Дания|7257.76|4|0|0|C|3|3||0|| L01BC05|GEMCITABINE|LH529|Gemsol|CONCENTRATE FOR SOLUTION FOR INFUSION|40 mg/ml - 25 ml|MG|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|35.92|1|4|0|C|8|1||1|| L01CD02|DOCETAXEL|LH530|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|MG|1|80|Булгермед ВЕ ООД, България|33.24|1|2|0|C||1||1|| L01CD02|DOCETAXEL|LH531|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|MG|1|160|Булгермед ВЕ ООД, България|66.47|1|2|0|C||1||1|| L01BB07|NELARABINE|LH532|Atriance|SOL. FOR INF.|5 mg/ml - 50ml|mg|1|250|Novartis Europharm Ltd., Ирландия|582.79|1|4|0|C||1||1|| L01XA01|CISPLATIN|LH533|Cisplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|10.72|1|4|0|C||1||1|| L01XA03|OXALIPLATIN|LH534|Oxaliplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Ebewe Pharma GmbH. N.fg. KG, Австрия|30.44|1|3|0|C||1||1|| L01XC07|BEVACIZUMAB|LH535|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Amgen Technology (Ireland) UC, Ирландия|1219.42|1|4|0|C|8|3||1|| L01XC07|BEVACIZUMAB|LH536|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Amgen Technology (Ireland) UC, Ирландия|310.2|1|4|0|C|8|3||1|| L01XE29|LENVATINIB|LH537|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, Германия|3039.62|4|0|0|C|3|3||0|| L01XC07|BEVACIZUMAB|LH538|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|MG|1|400|Pfizer Europe MA EEIG, Белгия|1219.42|1|4|0|C|8|3||1|| L01XC07|BEVACIZUMAB|LH539|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|MG|1|100|Pfizer Europe MA EEIG, Белгия|310.2|1|4|0|C|8|3||1|| L01CE02|IRINOTECAN|LH540|Onivyde pegylated liposomal|CONCENTRATE FOR DISPERSION FOR INFUSION|4.3 mg/ml - 10 ml|mg|1|43|Les Laboratoires Servier, Франция|1872.28|1|4|0|C|7|1||1|| L02BB05|APALUTAMIDE|LH541|Erleada|TABL. FILM. COAT.|60 mg|mg|120|7200|Janssen-Cilag International N.V., Белгия|6140.47|4|0|0|C|3|3||0|| L04AX04|LENALIDOMIDE|LH542|Lenalidomide Sandoz|CAPSULE, HARD|5 mg|mg|21|105|Sandoz d.d., Словения|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH543|Lenalidomide Sandoz|CAPSULE, HARD|10 mg|mg|21|210|Sandoz d.d., Словения|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH544|Lenalidomide Sandoz|CAPSULE, HARD|25 mg|mg|21|525|Sandoz d.d., Словения|3582.74|4|0|0|C|3|1||0|| L01XC33|CEMIPLIMAB|LH545|Libtayo|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|mg|1|350|Regeneron Ireland Designated Activity Company (DAC), Ирландия|8612.38|1|2|0|C|3|3||0|| L01EX13|GILTERITINIB|LH546|Xospata|TABL. FILM. COAT.|40 mg|mg|84|3360|Astellas Pharma Europe B.V., Нидерландия|36390.44|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH547|Lenalidomide Pharmascience|CAPSULE, HARD|25 mg|mg|21|525|Pharmascience International Ltd., Кипър|3582.74|4|0|0|C|3|1||0|| L01BA04|PEMETREXED|LH548|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Sandoz d.d., Словения|939.06|1|2|0|C|7|1||1|| L01BA04|PEMETREXED|LH549|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Sandoz d.d., Словения|1878.12|1|2|0|C|7|1||1|| L04AX04|LENALIDOMIDE|LH550|Lenalidomide Pharmascience|CAPSULE, HARD|5 mg|mg|21|105|Pharmascience International Ltd., Кипър|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH551|Lenalidomide Pharmascience|CAPSULE, HARD|10 mg|mg|21|210|Pharmascience International Ltd., Кипър|1433.1|4|0|0|C|3|1||0|| L01BC07|AZACITIDINE|LH552|Azacitidine Sandoz|POWD.SUSP|25mg/ml|mg|1|100|Sandoz d.d., Словения|207.48|3|1|0|C||1||1|| L01BC07|AZACITIDINE|LH553|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Pharmascience International Ltd., Кипър|311.22|3|1|0|C||1||1|| L01BC07|AZACITIDINE|LH554|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Pharmascience International Ltd., Кипър|207.48|3|1|0|C||1||1|| L01EX02|SORAFENIB|LH555|Sorafenib Pharmascience|TABL. FILM. COAT.|200 mg|mg|112|22400|Pharmascience International Ltd., Кипър|2222.38|4|0|0|C|3|3||0|| L01EX02|SORAFENIB|LH556|Nexavar|TABL. FILM. COAT.|200 mg|mg|112|22400|Bayer AG, Германия|6147.94|4|0|0|C|3|3||0|| L01ED05|LORLATINIB|LH558|Lorviqua|TABL. FILM. COAT.|100 mg|mg|30|3000|Pfizer Europe MA EEIG, Белгия|8763.24|4|0|0|C|3|3||0|| L01XC07|BEVACIZUMAB|LH559|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Mabxience Research SL, Испания|310.2|1|3|0|C|8|3||1|| L01XC07|BEVACIZUMAB|LH560|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Mabxience Research SL, Испания|1219.42|1|3|0|C|8|3||1|| L04AX04|LENALIDOMIDE|LH561|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|5 mg|mg|21|105|KRKA d.d., Словения|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH562|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|10 mg|mg|21|210|KRKA d.d., Словения|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH563|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|25 mg|mg|21|525|KRKA d.d., Словения|3582.74|4|0|0|C|3|1||0|| L01EX02|SORAFENIB|LH565|Sorafenib Sandoz|TABL. FILM. COAT.|200 mg|mg|112|22400|Sandoz d.d., Словения|2222.38|4|0|0|C|3|3||0|| L04AX04|LENALIDOMIDE|LH567|Lenalidomide G.L.|CAPSULE, HARD|5 mg|mg|21|105|G.L. Pharma GmbH, Австрия|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH568|Lenalidomide G.L.|CAPSULE, HARD|10 mg|mg|21|210|G.L. Pharma GmbH, Австрия|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH569|Lenalidomide G.L.|CAPSULE, HARD|25 mg|mg|21|525|G.L. Pharma GmbH, Австрия|3582.74|4|0|0|C|3|1||0|| L01BC07|AZACITIDINE|LH570|Gerodaza|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|G.L. Pharma GmbH, Австрия|207.48|3|1|0|C||1||1|| L01EX01|SUNITINIB|LH571|Suniticon|CAPSULE, HARD|50 mg|mg|30|1500|Фармаконс АД, България|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH572|Suniticon|CAPSULE, HARD|12.5 mg|mg|30|375|Фармаконс АД, България|1051.8|4|0|0|C|3|3||0|| L04AX04|LENALIDOMIDE|LH573|Lenalidomide Accord|CAPSULE, HARD|25 mg|mg|21|525|Accord Healthcare S.L.U., Испания|3582.74|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH574|Lenalidomide Accord|CAPSULE, HARD|10 mg|mg|21|210|Accord Healthcare S.L.U., Испания|1433.1|4|0|0|C|3|1||0|| L01XE10|EVEROLIMUS|LH576|Everolimus Sandoz|TABL|10 mg|mg|30|300|Sandoz d.d., Словения|2621.24|4|0|0|C|3|3||0|| L01ED05|LORLATINIB|LH577|Lorviqua|TABL. FILM. COAT.|25 mg|mg|90|2250|Pfizer Europe MA EEIG, Белгия|6572.43|4|0|0|C|3|3||0|| L01EB01|GEFITINIB|LH578|Gefiticon|TABL. FILM. COAT.|250 mg|mg|30|7500|Фармаконс АД, България|774.77|4|0|0|C|3|3||0|| L02BB06|DAROLUTAMIDE|LH579|Nubeqa|FILM-COATED TABLET|300 mg|mg|112|33600|Bayer AG, Германия|6624.34|4|0|0|C|3|3||0|| L01BC07|AZACITIDINE|LH580|Azacitidine Stada Arzneimittel|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Stada Arzneimittel AG, Германия|207.48|3|1|0|C||1||1|| L01XC07|BEVACIZUMAB|LH581|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Stada Arzneimittel AG, Германия|1219.42|1|3|0|C|8|3||1|| L01XC07|BEVACIZUMAB|LH582|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Stada Arzneimittel AG, Германия|310.2|1|3|0|C|8|3||1|| L01BC07|AZACITIDINE|LH583|Azacitidine Accord|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Accord Healthcare S.L.U., Испания|207.48|3|1|0|C||1||1|| L01EC03|ENCORAFENIB|LH584|Braftovi|CAPSULE, HARD|75 mg|mg|42|3150|Pierre Fabre Medicament, Франция|2646.06|4|0|0|C|3|3||0|| L01EC03|ENCORAFENIB|LH585|Braftovi|CAPSULE, HARD|50 mg|mg|28|1400|Pierre Fabre Medicament, Франция|1175.61|4|0|0|C|3|3||0|| L01EE03|BINIMETINIB|LH586|Mektovi|FILM-COATED TABLET|15 mg|mg|84|1260|Pierre Fabre Medicament, Франция|4473.46|4|0|0|C|3|3||0|| L01EX14|ENTRECTINIB|LH587|Rozlytrek|CAPSULE, HARD|200 mg|mg|90|18000|Roche Registration GmbH, Германия|10757.04|4|0|0|C|3|3||0|| L01FX14|POLATUZUMAB VEDOTIN|LH588|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|140 mg|mg|1|140|Roche Registration GmbH, Германия|22430.75|1|2|0|C|0|4||1|| L01FX14|POLATUZUMAB VEDOTIN|LH589|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|30 mg|mg|1|30|Roche Registration GmbH, Германия|4806.59|1|2|0|C|0|4||1|| L01EX01|SUNITINIB|LH590|Sunitinib Zentiva|CAPSULE, HARD|25 mg|mg|30|750|Zentiva k.s., Чешка република|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH591|Sunitinib Zentiva|CAPSULE, HARD|50 mg|mg|30|1500|Zentiva k.s., Чешка република|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH592|Sunitinib Zentiva|CAPSULE, HARD|12.5 mg|mg|30|375|Zentiva k.s., Чешка република|1051.8|4|0|0|C|3|3||0|| L01XE51|ACALABRUTINIB|LH593|Calquence|CAPSULE, HARD|100 mg|mg|56|5600|Astra Zeneca AB, Швеция|13300.08|4|0|0|C|3|3||0|| L01XY02|PERTUZUMAB, TRASTUZUMAB|LH594|Phesgo|SOLUTION FOR INJECTION|1200 mg/600 mg - 15ml|mg|1|1800|Roche Registration GmbH, Германия|13030.79|3|1|0|C|7|3||0|| L01XY02|PERTUZUMAB, TRASTUZUMAB|LH595|Phesgo|SOLUTION FOR INJECTION|600 mg/600 mg - 10 ml|mg|1|1200|Roche Registration GmbH, Германия|7238.4|3|1|0|C|7|3||0|| L04AX04|LENALIDOMIDE|LH596|Lenalidomide Pharmascience|CAPSULE, HARD|15 mg|mg|21|315|Pharmascience International Ltd., Кипър|2149.64|4|0|0|C|3|1||0|| L01EX01|SUNITINIB|LH597|Sunitinib Teva|CAPSULE, HARD|50 mg|mg|30|1500|Teva B.V, Нидерландия|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH598|Sunitinib Teva|CAPSULE, HARD|25 mg|mg|30|750|Teva B.V, Нидерландия|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH599|Sunitinib Teva|CAPSULE, HARD|12.5 mg|mg|30|375|Teva B.V, Нидерландия|1051.8|4|0|0|C|3|3||0|| L01EX02|SORAFENIB|LH600|Sorafecon|FILM-COATED TABLET|200 mg|mg|112|22400|Фармаконс АД, България|2222.38|4|0|0|C|3|3||0|| L01CD04|CABAZITAXEL|LH601|Cabazitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 3ml|mg|1|60|Accord Healthcare S.L.U., Испания|5248.72|1|2|0|C|7|1||1|| L01CD04|CABAZITAXEL|LH602|Eleber|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Zentiva k.s., Чешка република|5248.15|1|2|0|C|7|1||1|| L01EX01|SUNITINIB|LH603|Aluten|CAPSULE, HARD|50 mg|mg|30|1500|АЛУФАРМА БЪЛГАРИЯ ООД, България|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH604|Aluten|CAPSULE, HARD|25 mg|mg|30|750|АЛУФАРМА БЪЛГАРИЯ ООД, България|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH605|Sunitinib Mylan|CAPSULE, HARD|25 mg|mg|30|750|Mylan Ireland Limited, Ирландия|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH606|Sunitinib Mylan|CAPSULE, HARD|12.5 mg|mg|30|375|Mylan Ireland Limited, Ирландия|1051.8|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH607|Sunitinib Mylan|CAPSULE, HARD|50 mg|mg|30|1500|Mylan Ireland Limited, Ирландия|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH608|Sunitinib Pharmascience|CAPSULE, HARD|50 mg||30|1500|Pharmascience International Ltd., Кипър|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH609|Sunitinib Pharmascience|CAPSULE, HARD|37.5 mg|mg|30|1125|Pharmascience International Ltd., Кипър|3155.41|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH610|Sunitinib Pharmascience|CAPSULE, HARD|12.5 mg|mg|30|375|Pharmascience International Ltd., Кипър|1051.8|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH611|Sunitinib Pharmascience|CAPSULE, HARD|25 mg|mg|30|750|Pharmascience International Ltd., Кипър|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH612|Sunitinib Sandoz|CAPSULE, HARD|50 mg|mg|30|1500|Sandoz d.d., Словения|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH613|Sunitinib Sandoz|CAPSULE, HARD|25 mg|mg|30|750|Sandoz d.d., Словения|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH614|Sunitinib Sandoz|CAPSULE, HARD|12.5 mg|mg|30|375|Sandoz d.d., Словения|1051.8|4|0|0|C|3|3||0|| L04AX04|LENALIDOMIDE|LH615|Lenalidomide Grindeks|CAPSULE, HARD|5 mg|mg|21|105|AS Grindeks, Латвия|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH616|Lenalidomide Grindeks|CAPSULE, HARD|10 mg|mg|21|210|AS Grindeks, Латвия|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH617|Lenalidomide Grindeks|CAPSULE, HARD|25 mg|mg|21|525|AS Grindeks, Латвия|3582.74|4|0|0|C|3|1||0|| L01BC53|TEGAFUR/GIMERACIL/OTERACIL|LH618|Teysuno|CAPSULE, HARD|20 mg/5,8 mg/15,8 mg|MG|42|840|Nordic Group BV, Холандия|311.82|4|0|0|C|3|1||0|| L01FC01|DARATUMUMAB|LH619|Darzalex|SOLUTION FOR INJECTION|1800 mg-15 ml|mg|1|1800|Janssen-Cilag International N.V., Белгия|10263.68|3|1|0|C||4||0|| L01EX03|PAZOPANIB|LH620|Pazopanib Pharmascience|TABLETS FILM COATED|400 mg|mg|60|24000|Pharmascience International Ltd., Кипър|2816.1|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH621|Pazopanib Pharmascience|TABLETS FILM COATED|200 mg|mg|30|6000|Pharmascience International Ltd., Кипър|704.03|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH622|Suganet|CAPSULE, HARD|12.5 mg|mg|30|375|Gedeon Richter Plc., Унгария|1051.8|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH623|Suganet|CAPSULE, HARD|25 mg|mg|30|750|Gedeon Richter Plc., Унгария|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH624|Suganet|CAPSULE, HARD|50 mg|mg|30|1500|Gedeon Richter Plc., Унгария|4207.21|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH625|Sunitinib Accord|CAPSULE, HARD|25 mg|mg|30|750|Accord Healthcare S.L.U., Испания|2103.61|4|0|0|C|3|3||0|| L01EX01|SUNITINIB|LH626|Sunitinib Accord|CAPSULE, HARD|50 mg|mg|30|1500|Accord Healthcare S.L.U., Испания|4207.21|4|0|0|C|3|3||0|| L01EA01|IMATINIB|LH627|Imatinib Accord|TABLETS FILM COATED|100 mg|mg|120|12000|Accord Healthcare S.L.U., Испания|170.87|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH628|Alunib|TABLETS FILM COATED|400 mg|mg|60|24000|АЛУФАРМА БЪЛГАРИЯ ООД, България|2816.1|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH629|Alunib|TABLETS FILM COATED|200 mg|mg|30|6000|АЛУФАРМА БЪЛГАРИЯ ООД, България|704.03|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH630|Pazopanib Teva|TABLETS FILM COATED|400 mg|mg|60|24000|Teva B.V, Нидерландия|2816.1|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH631|Pazopanib Teva|TABLETS FILM COATED|200 mg|mg|30|6000|Teva B.V, Нидерландия|704.03|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH632|Pazopanib Zentiva|TABLETS FILM COATED|400 mg|mg|60|24000|Zentiva k.s., Чешка република|2816.1|4|0|0|C|3|3||0|| L01EX03|PAZOPANIB|LH633|Pazopanib Zentiva|TABLETS FILM COATED|200 mg|mg|30|6000|Zentiva k.s., Чешка република|704.03|4|0|0|C|3|3||0|| L01XX32|BORTEZOMIB|LH634|Bortezomib Accord|SOLUTION FOR INJECTION|2.5 mg/ml - 1.4 ml|mg|1|3.5|Accord Healthcare S.L.U., Испания|150|1|4|0|C||3||1|| L01XK04|TALAZOPARIB|LH635|Talzenna|CAPSULE, HARD|0.25 mg|mg|30|7.5|Pfizer Europe MA EEIG, Белгия|2307.57|4|0|0|C|3|3||0|| L01XK04|TALAZOPARIB|LH636|Talzenna|CAPSULE, HARD|1 mg|mg|30|30|Pfizer Europe MA EEIG, Белгия|9230.29|4|0|0|C|3|3||0|| L02BX03|ABIRATERONE ACETATE|LH637|Abiraterone G.L.|FILM-COATED TABLET|500 mg|mg|60|30000|G.L. Pharma GmbH, Австрия|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH638|Abiraterone Krka|FILM-COATED TABLET|500 mg|mg|60|30000|KRKA d.d., Словения|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH639|Abiraterone Pharmascience|FILM-COATED TABLET|500 mg|mg|60|30000|Pharmascience International Ltd., Кипър|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH640|Abiraterone Richter|FILM-COATED TABLET|500 mg|mg|60|30000|Gedeon Richter Plc., Унгария|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH641|Abirateron Sandoz|FILM-COATED TABLET|500 mg|mg|60|30000|Sandoz d.d., Словения|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH642|Abirateron Zentiva|FILM-COATED TABLET|500 mg|mg|60|30000|Zentiva k.s., Чешка република|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH643|Abiraterone Mylan|FILM-COATED TABLET|500 mg|mg|60|30000|Mylan Ireland Limited, Ирландия|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH644|Abiraterone Mylan|FILM-COATED TABLET|1000 mg|mg|30|30000|Mylan Ireland Limited, Ирландия|1903.12|4|0|0|C|3|2||0|| L02BX03|ABIRATERONE ACETATE|LH645|Abiraterone Accord|TABLETS FILM COATED|500 mg|mg|60|30000|Accord Healthcare S.L.U., Испания|1903.12|4|0|0|C|3|2||0|| L01EX02|SORAFENIB|LH649|Sorafenib Teva|FILM-COATED TABLET|200 mg|MG|112|22400|Teva B.V, Нидерландия|2222.38|4|0|0|C|3|3||0|| L01XC03|TRASTUZUMAB|LH650|Zercepac|CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|MG|1|150|Accord Healthcare S.L.U., Испания|434.46|1|4|0|C||3||1|| L01EA02|DASATINIB|LH651|Dasatinib Zentiva|FILM-COATED TABLET|50 mg|MG|60|3000|Zentiva k.s., Чешка република|2644.67|4|0|0|C|3|3||0|| L01EA02|DASATINIB|LH652|Dasatinib Teva|FILM-COATED TABLET|50 mg|MG|30|1500|Teva B.V, Нидерландия|1322.34|4|0|0|C|3|3||0|| L02BX03|ABIRATERONE ACETATE|LH653|Abiraterone STADA|FILM-COATED TABLET|500 mg|mg|60|30000|Stada Arzneimittel AG, Германия|1903.12|4|0|0|C|3|2||0|| L01EX14|ENTRECTINIB|LH656|Rozlytrek|CAPSULE, HARD|100 mg|LH|30|3000|Roche Registration GmbH, Германия|1792.84|4|0|0|C|3|3||0|| L02BX03|ABIRATERONE ACETATE|LH657|Abiraterone Teva|TABLETS FILM COATED|500 mg||60|30000|Teva B.V, Нидерландия|1903.12|4|0|0|C|3|2||0|| M05BA08|ZOLEDRONIC ACID|MH012|Zoledronic acid Actavis|CONCENTRATE FOR SOLUTION FOR INFUSION|4mg/5ml|mg|1|4|Actavis Group PTC ehf., Исландия|22.91|1|4|0|C||6||0|| M05BX04|Denosumab|MH017|Xgeva|sol. for inj.|120 mg/1.7ml|mg|1|120|Amgen Europe B.V., Нидерландия|550.85|3|1|0|C|8|6||0|| M05BA08|ZOLEDRONIC ACID|MH022|Zolendronic acid Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|Accord Healthcare S.L.U., Испания|22.91|1|4|0|C||6||0|| N02AA01|Morphine|NO572|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 100|sol. inj.|20mg/ml-1ml|mg|100|2000|Софарма АД, България|144.77|2|0|1|C||||0|| N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|50mg/ml-2ml|mg|10|1000|Софарма АД, България|12.89|2|0|1|C||||0|| N02AB02|Pethidine hydrochloride|NO589|LYDOL sol.for inj. 50 mg/ml- 2 ml x 50|solution for injection|50mg/ml-2 ml|mg|50|5000|Софарма АД, България|64.44|2|0|1|C||||0|| N02AB03|FENTANYL|NO590|Victanyl|TRANSDERMAL PATCHES|75 mcg/h|mcg|5|375|Teva B.V, Нидерландия|36.58|4|0|1|C||||0|| N02AB03|FENTANYL|NO592|Victanyl|TRANSDERMAL PATCHES|50 mcg/h|mcg|5|250|Teva B.V, Нидерландия|24.39|4|0|1|C||||0|| N02AB03|FENTANYL|NO593|Victanyl|TRANSDERMAL PATCHES|100 mch/h|mcg|5|500|Teva B.V, Нидерландия|48.77|4|0|1|C||||0|| N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20mg/ml-1ml|mg|10|200|Софарма АД, България|14.48|2|0|1|C||||0|| N02AA05|OXYCODONE|NO600|Oxycodone Actavis|CAPSULE, HARD|10 mg|mg|50|500|Teva B.V, Нидерландия|8.5|4|0|1|C||||0|| N02AA05|OXYCODONE|NO601|Oxycodone Actavis|CAPSULE, HARD|20 mg|mg|50|1000|Teva B.V, Нидерландия|16.98|4|0|1|C||||0|| N02AE01|BUPRENORPHINE|NO604|Buprenorphin Actavis|TRANSDERMAL PATCH|35 mcg/h|mcg|5|175|Teva B.V, Нидерландия|25.23|4|0|1|C||||0|| N02AE01|BUPRENORPHINE|NO605|Buprenorphin Actavis|TRANSDERMAL PATCH|52,5 mcg/h|mcg|5|262.5|Teva B.V, Нидерландия|37.85|4|0|1|C||||0|| N02AE01|BUPRENORPHINE|NO606|Buprenorphin Actavis|TRANSDERMAL PATCH|70 mcg/h|mcg|5|350|Teva B.V, Нидерландия|50.47|4|0|1|C||||0|| N02AA01|Morphine|NO610|Doltard|prolong release tabl.|30|mg|100|3000|Takeda Pharma A/S, Дания|21.37|4|0|1|C||||0|| N02AX02|Tramadol|NO611|TRAMADOL STADA|sol. for inj.| 50 mg/ml - 2 ml|mg|5|500|Stada Arzneimittel AG, Германия|4.88|2|0|1|C||||0|| N02AA05|OXYCODONE|NO612|Oxycodone Actavis|TABL. RELEASE PROLONG|10 mg|mg|50|500|Teva B.V, Нидерландия|8.5|4|0|1|C||||0|| N02AA05|OXYCODONE|NO613|Oxycodone Actavis|TABL. RELEASE PROLONG|20 mg|mg|50|1000|Teva B.V, Нидерландия|16.98|4|0|1|C||||0|| N02AA05|OXYCODONE|NO614|Oxycodone Actavis|TABL. RELEASE PROLONG|40 mg|mg|50|2000|Teva B.V, Нидерландия|33.97|4|0|1|C||||0|| N02AA05|Oxycodone hydrochloride|NO617|Oxylan|prolonged- release tablets|20|mg|50|1000|G.L. Pharma GmbH, Австрия|16.98|4|0|1|C||||0|| N02AA05|Oxycodone hydrochloride|NO618|Oxylan|prolonged- release tablets|40|mg|50|2000|G.L. Pharma GmbH, Австрия|33.97|4|0|1|C||||0|| N02AA05|Oxycodone hydrochloride|NO619|Oxylan|prolonged- release tablets|80|mg|50|4000|G.L. Pharma GmbH, Австрия|67.93|4|0|1|C||||0|| N02AB03|Fentanyl|NO621|Vellofent|Sublingual tablet|133 mcg|mcg|4|532|Анджелини Фарма България ЕООД, България|33.66|4|0|1|C||||0|| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO627|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|10mg/5mg|mg|50|500|Teva B.V, Нидерландия|30.21|4|0|1|C||||0|| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO628|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|20mg/10mg|mg|50|1000|Teva B.V, Нидерландия|60.37|4|0|1|C||||0|| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO629|Geroxynal|TABL. RELEASE PROLONG|10 mg/5 mg|mg|50|500|G.L. Pharma GmbH, Австрия|30.21|4|0|1|C||||0|| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO630|Geroxynal|TABL. RELEASE PROLONG|20 mg/ 10 mg|mg|50|1000|G.L. Pharma GmbH, Австрия|60.37|4|0|1|C||||0|| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO631|Geroxynal|TABL. RELEASE PROLONG|40 mg/ 20 mg|mg|50|2000|G.L. Pharma GmbH, Австрия|120.79|4|0|1|C||||0|| N02AJ13|TRAMADOL/PARACETAMOL|NO632|Paratramol|TABL. FILM. COAT.|37.5MG/325MG|mg|90|32625|Pharmaceutical Works Polpharma S.A., Полша|16.49|4|0|1|C||||0|| N02AB03|FENTANYL|NO633|Fentadolor|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|Sandoz d.d., Словения|50.48|4|0|1|C||||0|| N02AB03|FENTANYL|NO634|Sublifen|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|G.L. Pharma GmbH, Австрия|50.48|4|0|1|C||||0|| N02AA08|Dihydrocodeine|NP414|DHC Continus|modified-release tablets|90|mg|50|4500|Mundipharma GmbH, Австрия|27.86|4|0|1|C||||0|| N02AX02|Tramadol|NP415|TRAMALGIN sol.for inj. 50 mg/ml-2 ml x10|sol.for inj.|50 mg/ml-2 ml|mg|10|1000|Софарма АД, България|9.76|2|0|1|C||||0|| N02AX02|Tramadol|NP419|TRAMADOL STADA|caps. hard|50|mg|30|1500|Stada Arzneimittel AG, Германия|4.28|4|0|1|C||||0|| N02AX02|TRAMADOL|NP420|Tramalgin|CAPSULES|50 mg|mg|20|1000|Софарма АД, България|2.85|4|0|1|C||||0|| V03AC01|Deferoxamine|VH009|Desferal|powder for solution for injection|500|mg|10|5000|Novartis Pharma GmbH, Германия|53.58|1|4|0|C|1|||0|| V03AF03|CALCIUM FOLINATE|VH015|Bendafolin|SOL.FOR INJ|10mg/ml-100ml|mg|1|1000|Lyomark Pharma GmbH, Germany|120.18|1|0|0|C|0|1||1|| V03AF03|CALCIUM FOLINATE|VH018|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|1|100|Sandoz d.d., Словения|12.04|1|0|0|C|0|1||1|| V03AF03|CALCIUM FOLINATE|VH019|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 mg/ml - 5 ml|mg|5|250|Sandoz d.d., Словения|30.06|1|0|0|C|0|1||1|| V03AC03|DEFERASIROX|VH020|Exjade|FILM-COATED TABLET|180 mg|mg|30|5400|Novartis Europharm Ltd., Ирландия|217.73|4|0|0|C|3|||0|| V03AF01|Mesna|VH021|UROMITEXAN|SOLUTION FOR INJECTION|100 mg/ml - 4 ml|mg|15|6000|Екофарм Груп АД, България|127.51|1|4|0|C|10|1||1|| V03AC02|DEFERIPRONE|VH022|Deferiprone Lipomed|TABL. FILM. COAT.|500 mg|mg|100|50000|Lipomed GmbH, Germany|271.57|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH023|Deferasirox Mylan|TABLETS FILM COATED|180 mg|mg|30|5400|Mylan Pharmaceuticals Limited, Ирландия|217.73|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH024|Deferasirox Pharmascience|FILM-COATED TABLET|180 mg|MG|30|5400|Pharmascience International Ltd., Кипър|217.73|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH025|Deferasirox Teva|FILM-COATED TABLET|180 mg|MG|30|5400|Тева Фарма ЕАД, България|217.73|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH026|Zeoks|FILM-COATED TABLET|180 mg|mg|30|5400|Zentiva k.s., Чешка република|217.73|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH027|Ferupantil|TABLETS FILM COATED|180 mg|mg|30|5400|Sandoz Pharmaceuticals d.d., Словения|217.73|4|0|0|C|3|||0|| V03AF03|CALCIUM FOLINATE|VH028|Calcium folinate Alupharma|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|1|100|АЛУФАРМА БЪЛГАРИЯ ООД, България|12.04|1|0|0|C|0|1||1|| V03AF03|CALCIUM FOLINATE|VH029|Calcium folinate Alupharma|SOLUTION FOR INJECTION/INFUSION|10mg/ml-50ml|mg|1|500|АЛУФАРМА БЪЛГАРИЯ ООД, България|60.06|1|0|0|C|0|1||1|| V03AC03|DEFERASIROX|VH030|Deferasirox Accord|TABLETS FILM COATED|180 mg|mg|30|5400|Accord Healthcare S.L.U., Испания|217.73|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH031|Deferasirox Teva|TABLETS FILM COATED|900mg|mg|30|27000|Тева Фарма ЕАД, България|1088.64|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH032|Ziadex|TABLETS FILM COATED|360mg|mg|30|10800|Нобел Фарма ЕООД, България|435.46|4|0|0|C|3|||0|| V03AC03|DEFERASIROX|VH033|Ziadex|TABLETS FILM COATED|180 mg|mg|30|5400|Нобел Фарма ЕООД, България|217.73|4|0|0|C|3|||0||